title: Voglibose: an alpha glucosidase inhibitor.
abstract: Diabetes Mellitus (DM) is a morbid disease worldwide, with increasing incidence as time passes. It has macro-vascular and micro-vascular complications. The main cause of these complications is poorly controlled postprandial hyperglycaemia. Alpha glucosidase inhibitors, namely acarbose, voglibose and miglitol, are available for therapy. Voglibose is well tolerated and effective in comparable doses among these drugs. This article highlights the important features of voglibose.
authors.affiliation: Associate Professor, Department of Medicine, Medical College and Sir Sayajirao General Hospital , Gujarat, India .
authors.forename: Ajay S
authors.initials: AS
authors.lastname: Dabhi
authors.affiliation: Intern, Department of Medicine, Medical College and Sir Sayajirao General Hospital , Gujarat, India .
authors.forename: Nikita R
authors.initials: NR
authors.lastname: Bhatt
authors.affiliation: Resident, Department of Medicine, Medical College and Sir Sayajirao General Hospital , Gujarat, India .
authors.forename: Mohit J
authors.initials: MJ
authors.lastname: Shah
keywords: Alpha glucosidase inhibitors (αGI); Postprandial hyperglycaemia (PPHG)